- Home
- MYFW vs BDTX Comparison
MYFW vs BDTX Comparison
Compare MYFW & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- BDTX
- Stock Information
- Founded
- MYFW 2002
- BDTX 2014
- Country
- MYFW United States
- BDTX United States
- Employees
- MYFW N/A
- BDTX N/A
- Industry
- MYFW Major Banks
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYFW Finance
- BDTX Health Care
- Exchange
- MYFW Nasdaq
- BDTX Nasdaq
- Market Cap
- MYFW 201.1M
- BDTX 181.4M
- IPO Year
- MYFW 2018
- BDTX 2020
- Fundamental
- Price
- MYFW $22.99
- BDTX $2.92
- Analyst Decision
- MYFW Buy
- BDTX Strong Buy
- Analyst Count
- MYFW 2
- BDTX 5
- Target Price
- MYFW $24.25
- BDTX $13.40
- AVG Volume (30 Days)
- MYFW 46.3K
- BDTX 918.1K
- Earning Date
- MYFW 07-24-2025
- BDTX 08-07-2025
- Dividend Yield
- MYFW N/A
- BDTX N/A
- EPS Growth
- MYFW 226.95
- BDTX N/A
- EPS
- MYFW 1.18
- BDTX 0.25
- Revenue
- MYFW $93,514,000.00
- BDTX $70,000,000.00
- Revenue This Year
- MYFW $14.41
- BDTX N/A
- Revenue Next Year
- MYFW $12.25
- BDTX N/A
- P/E Ratio
- MYFW $18.31
- BDTX $11.64
- Revenue Growth
- MYFW 16.68
- BDTX N/A
- 52 Week Low
- MYFW $16.77
- BDTX $1.20
- 52 Week High
- MYFW $24.88
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- MYFW 61.39
- BDTX 57.52
- Support Level
- MYFW $21.35
- BDTX $2.56
- Resistance Level
- MYFW $21.96
- BDTX $2.84
- Average True Range (ATR)
- MYFW 0.70
- BDTX 0.20
- MACD
- MYFW 0.15
- BDTX 0.02
- Stochastic Oscillator
- MYFW 99.62
- BDTX 85.35
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.